What Are The Estimated Market Size And CAGR For The Heart Pump Devices Market Between 2026 And 2030?
The heart pump devices market size has grown rapidly in recent years. It will grow from $4.48 billion in 2025 to $5.32 billion in 2026 at a compound annual growth rate (CAGR) of 19.0%. The growth in the historic period can be attributed to rising incidence of heart failure, expansion of cardiac surgery programs, advancements in mechanical pump design, increasing transplant wait times, growing use of extracorporeal support systems.
The heart pump devices market size is expected to see rapid growth in the next few years. It will grow to $10.37 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing demand for long-term circulatory support, rising adoption of destination therapy devices, expansion of minimally invasive cardiac procedures, growing integration of smart monitoring technologies, increasing investments in advanced cardiac care. Major trends in the forecast period include increasing use of advanced ventricular assist devices, rising adoption of temporary mechanical circulatory support, growing focus on miniaturized implantable pumps, expansion of bridge-to-transplant therapies, enhanced monitoring of hemodynamic performance.
Claim Your Free Report Sample Today:
What Essential Growth Drivers Are Pushing The Heart Pump Devices Market Forward?
The increasing prevalence of cardiovascular disorders is expected to propel the heart pump devices market going forward. Cardiovascular disorders refer to a term for the conditions affecting the heart or blood vessels. The rise in cardiovascular diseases would require advanced diagnostics and treatments such as heart pump devices that help pump blood from the lower left heart chamber that is used to help maintain blood flow during high-risk protected percutaneous coronary interventions, which would increase the demand for the market. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the heart pump devices market.
Which Segment Groups Play A Crucial Role In Outlining The Heart Pump Devices Market’s Structure?
The heart pump devices market covered in this report is segmented –
1) By Type: Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices
2) By Therapy: Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT), Other Therapies
3) By End-user: Hospitals, Cardiac Specialty Hospitals / Heart Centers, Transplant Centers, Other End-Users
Subsegments:
1) By Implantable Heart Pump Devices: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BiVADs), Total Artificial Hearts (TAHs)
2) By Extracorporeal Heart Pump Devices: Intra-Aortic Balloon Pumps (IABPs), Ventricular Assist Devices (Temporary): Centrifugal Blood Pumps
What New Trends Are Beginning To Take Shape Within The Heart Pump Devices Market?
Major companies operating in the heart pump devices market are developing extracorporeal membrane oxygenation (ECMO) systems to provide advanced life support for patients with severe heart and lung conditions. Extracorporeal membrane oxygenation (ECMO) systems refer to advanced life support machines used to provide prolonged cardiac and respiratory support for patients whose heart and lungs are unable to function properly. For instance, in September 2024, Medtronic plc, an Ireland-based medical device company, launched VitalFlow system, an innovative extracorporeal membrane oxygenation (ECMO) solution designed to provide circulatory support for patients with severe heart or lung failure. The VitalFlow system functions as a heart pump by using a pump and oxygenator to take over the work of the heart and lungs. This is crucial for patients experiencing life-threatening conditions, allowing their organs to rest and heal.
Which Companies Represent The Key Strategic Forces Within The Heart Pump Devices Market?
Major companies operating in the heart pump devices market are Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova plc, SynCardia Systems Inc, CARMAT SA, Jarvik Heart Inc, BiVACOR Inc, CorWave SA, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Nipro Corporation, Eurosets Srl, CardioBridge GmbH, Hemovent GmbH, Evaheart Inc, Calon Cardio-Technology Ltd, Lepu Medical Technology Co Ltd, NewHeart Technologies Inc
Get Your In-Depth Heart Pump Devices Market Report Now:
What Are The Fastest-Expanding Regions Contributing To The Growth Of The Heart Pump Devices Market?
North America was the largest region in the heart pump devices market share in 2025. The regions covered in the heart pump devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment